Official registry condition

Metabolic Syndrome peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Metabolic Syndrome. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

5 profiles.

Registry update years

2015–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 286 selected PubMed records and 25 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Metabolic Syndrome unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00657605

PeptideScanner retained ClinicalTrials.gov record NCT00657605 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.

PeptideScanner change date
November 16, 2026
Cited source date
February 13, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00659828

PeptideScanner retained ClinicalTrials.gov record NCT00659828 at 2026-11-16T17:35:38.955Z. Its registry update date was 2020-02-13, and PeptideScanner's reviewed identity mapping was metreleptin.

PeptideScanner change date
November 16, 2026
Cited source date
February 13, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02102646

PeptideScanner retained ClinicalTrials.gov record NCT02102646 at 2026-11-15T21:49:16.513Z. Its registry update date was 2015-10-28, and PeptideScanner's reviewed identity mapping was triptorelin.

PeptideScanner change date
November 15, 2026
Cited source date
October 28, 2015
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →